Bioavailability of two brands of quinidine gluconate administered on a multiple-dose regimen
Smith, T.C.; Kinkel, A.W.
Current Therapeutic Research 21(1): 128-134
1977
ISSN/ISBN: 0011-393X PMID: 401707 Document Number: 118785
Document emailed within 1 workday
Related Documents
Marr, J.; Gerlinger, C.; Kunz, M. 2012: A historical cycle control comparison of two drospirenone-containing combined oral contraceptives: ethinylestradiol 30 μg/drospirenone 3 mg administered in a 21/7 regimen versus ethinylestradiol 20 μg/drospirenone 3 mg administered in a 24/4 regimen European Journal of Obstetrics Gynecology and Reproductive Biology 162(1): 91-95Seth, S.D.; Beotra, A.; Seth, S. 1995: Comparative bioavailability of two brands of ciprofloxacin Journal of the Association of Physicians of India 43(5): 327-330
Suthakaran, C.; Rajaram, S.; Adithan, C. 1992: Comparative bioavailability of two brands of ciprofloxacin: an Indian study International Journal of Clinical Pharmacology Therapy and Toxicology 30(2): 66-68
Terhaag, B.; Le Petit, G.; Pachaly, C.; Feller, K. 1985: The in vitro liberation and the bioavailability of different brands of griseofulvin in plasma and urine in man International Journal of Clinical Pharmacology Therapy and Toxicology 23(9): 475-479
Janssen, T.J.; Guelen, P.J.; Vree, T.B.; Botterblom, M.H.; Valducci, R. 1988: Bioavailability of ambroxol sustained release preparations. Part II: Single and multiple oral dose studies in man Arzneimittel-Forschung 38(1): 95-97
Kobayashi, S.; Kyui, S.; Yoshida, T.; Nagakura, A.; Oiwa, Y.; Matsumura, R.; Kohei, H. 1981: Absorption, distribution and excretion of 14C-pirenzepine in rats. Accumulation characteristics after multiple dose regimen Arzneimittel-Forschung 31(4): 679-690
Farfel, Z.; Levi, A.; Millman, P.; Tamari, I.; Halkin, H. 1977: The bioavailability of Israeli quinidine preparations Harefuah 93(7-8): 207-208
Kakuda, T.N.; Schöller-Gyüre, M.; Workman, C.; Arasteh, K.; Pozniak, A.L.; De Smedt, G.; Beets, G.; Peeters, M.; Vandermeulen, K.; Woodfall, B.J.; Hoetelmans, R.M.W. 2008: Single- and multiple-dose pharmacokinetics of etravirine administered as two different formulations in HIV-1-infected patients Antiviral Therapy 13(5): 655-661
Fleishaker, J.C.; Hulst, L.K.; Peters, G.R. 1994: Multiple-dose tolerability and pharmacokinetics of tirilazad mesylate at doses of up to 10 mg/kg/day administered over 5-10 days in healthy volunteers International Journal of Clinical Pharmacology and Therapeutics 32(5): 223-230
Nyberg, L.; Andersson, K.E.; Fagerström, P.O. 1977: Bioavailability of digoxin from tablets. IV. Urinary excretion of digoxin during multiple dose treatment Acta Pharmaceutica Suecica 14(2): 119-136
Imataki, O.; Aoyama, T.; Tamai, Y.; Kawakami, K. 2007: Comparison of regimen-related toxicity between high-dose melphalan and ICE as a preparatory regimen for autologous stem cell transplantation Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(10): 1633-1636
Thornfeldt, C.; Rizer, R.L.; Trookman, N.S. 2013: Blockade of melanin synthesis, activation and distribution pathway by a nonprescription natural regimen is equally effective to a multiple prescription-based therapeutic regimen Journal of Drugs in Dermatology: Jdd 12(12): 1449-1454
Rapp, R.P.; Connors, J.E.; Hager, W.D.; Donaldson, E.S.; van Nagell, J.R. 1986: Comparison of single-dose moxalactam and a three-dose regimen of cefoxitin for prophylaxis in vaginal hysterectomy Clinical Pharmacy 5(12): 988-993
Laffi, R.; Tossani, N.; Marchi-Marchetti, M. 1985: Bioavailability of the thiamin administered as an adduct with menadione International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift für Vitamin- und Ernahrungsforschung. Journal International de Vitaminologie et de Nutrition 55(2): 181-185
Bhandari, P. 1999: Bioequivalence of two brands of sustained release theophylline brands Journal of the Association of Physicians of India 47(4): 461
Ramis, J.; Gich, I.; Torrent, J.; Mis, R.; Jané, F.; Forn, J. 1989: Bioavailability study of fosfosal and codeine administered alone or in combination International Journal of Clinical Pharmacology Therapy and Toxicology 27(7): 352-357
Proietti, A.; Murer, B.; Muretto, P.; Andreani, M.; Lucarelli, G.; Di Pietrantonj, F. 1991: Biologic effects of total body irradiation with single dose administered with various dose-rate Minerva Medica 82(11): 723-731
Fingerová, H.; Oborná, I.; Petrová, P.; Budíková, M.; Jezdínský, J. 2003: Does grapefruit juice increase the bioavailability of orally administered sex steroids? Ceska Gynekologie 68(2): 117-121
Palma-Aguirre, J.A.; Rosas-Alcázar, G.; Rodríguez, J.M.; León-Urrea, F.; Montoya-Cabrera, M.A. 1989: Bioavailability and pharmacokinetics of nifedipine administered by different routes in healthy volunteers Archivos de Investigacion Medica 20(2): 129-135
Leucuta, S.; Pop, R.; Kory, M.; Toader, S.; Böhm, B.; Melian, E. 1979: Pharmacokinetics and bioavailability of lithium administered to dogs as monoglutamate and carbonate Pharmaceutica Acta Helvetiae 54(11): 343-346